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Abstract
Background: Hypoxia-inducible factor 1 (HIF)-1a is a transcription factor that functions as master regulator of mammalian
oxygen homeostasis. In addition, recent studies identified a role for HIF-1a as transcriptional regulator during inflammation
or infection. Based on studies showing that respiratory syncytial virus (RSV) is among the most potent biological stimuli to
induce an inflammatory milieu, we hypothesized a role of HIF-1a as transcriptional regulator during infections with RSV.
Methodology, Principal Findings: We gained first insight from immunohistocemical studies of RSV-infected human
pulmonary epithelia that were stained for HIF-1a. These studies revealed that RSV-positive cells also stained for HIF-1a,
suggesting concomitant HIF-activation during RSV infection. Similarly, Western blot analysis confirmed an approximately 8-
fold increase in HIF-1a protein 24 h after RSV infection. In contrast, HIF-1a activation was abolished utilizing UV-treated RSV.
Moreover, HIF-a-regulated genes (VEGF, CD73, FN-1, COX-2) were induced with RSV infection of wild-type cells. In contrast,
HIF-1a dependent gene induction was abolished in pulmonary epithelia following siRNA mediated repression of HIF-1a.
Measurements of the partial pressure of oxygen in the supernatants of RSV infected epithelia or controls revealed no
differences in oxygen content, suggesting that HIF-1a activation is not caused by RSV associated hypoxia. Finally, studies of
RSV pneumonitis in mice confirmed HIF-a-activation in a murine in vivo model.
Conclusions/Significance: Taking together, these studies suggest hypoxia-independent activation of HIF-1a during
infection with RSV in vitro and in vivo.
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Introduction
A number of elegant studies, exemplified by those defining
induction of the erythropoietin (EPO) gene [1,2], have utilized
multidisciplinary approaches to elucidate basic hypoxia-adaptive
responses. Today, convincing evidence confirms a central role of
hypoxia-inducible factor (HIF)-1 in mammalian oxygen homeo-
stasis [3–6]. Such studies demonstrated that HIF-1 is composed of
two subunits: constitutively expressed HIF-1b and oxygen-
regulated HIF-1a. Under normoxic conditions, HIF-1a is
subjected to hydroxylation on proline residues [7]. The modifi-
cation is required for the binding of the von Hippel-Lindau (VHL)
tumor suppressor protein, the recognition component of an E3
ubiquitin-protein ligase that targets HIF-1a for proteasomal
degradation. Under hypoxic conditions, hydroxylation is inhibited
and the VHL protein does not bind to HIF-1, eventually leading to
stabilization of the alpha-subunit, heterodymerization, nuclear
translocation and transcription of HIF-dependent genes.
For example, binding of HIF-1 to consensus domains in the
erythropoietin promoter results in the transcriptional induction of
HIF-1-bearing gene promoters [8]. A series of experiments by
Wang and Semenza [9–11] and Maxwell et al. [12] demonstrated
that reporter genes containing the erythropoetin enhancer were
induced by hypoxia in a variety of cell types that did not normally
produce erythropoitin. Subsequently, it was determined that HIF-
1 is widely expressed and that consensus HIF-1 binding sequences
exist in a number of genes other than that of erythropoitin, and
were termed hypoxia responsive elements (HRE [8]). In particular,
HIF-1 has been found to regulate multiple genes that include HRE
in their promoter region, including vascular endothelial growth
factor (VEGF), insulin-like growth factors (IGFs), their binding
proteins [insuline-like growth factor binding proteins (IGFBPs)]
and iron supply regulating genes [e.g. transferrin [13]]. Thus, the
discovery of HIF-1 represented a major advance in the
understanding of gene regulation by hypoxia. Such studies have
led to an understanding that induction of HIF-1 responsive genes
drives altered cellular metabolism, increased vascular mass and
diameter and increased oxygen carrying capacity of the blood; all
events which are conducive to an adaptive response to diminished
oxygen supply [1,14–16].
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additional role of HIF-1a as transcriptional regulator of inflam-
mation and infection. For example, HIF-1a is essential for myeloid
cell-mediated inflammation, bactericidal capacity of phagocytes
[17] and mice with conditional knockouts of HIF-1a show
profound impairment of myeloid cell aggregation, motility,
invasiveness, and bacterial killing [18]. Moreover, studies of
HIF-1a during infection with enterobacteriaceae revealed hypox-
ia-independent activation by bacterial siderophores [19]. Similar-
ly, HIF-1a has been identified as key regulator of the inflammatory
transcription factor NF-kB [20]. Other studies confirmed several
parallels between the transcriptional regulation of hypoxia and
inflammation/infection [21-27]. For example, a recent study
suggests that NF-kB is a critical transcriptional activator of HIF-1a
and that basal NF-kB activity is required for HIF-1 protein
accumulation under hypoxia [28]. Similarly, studies of human
pathogens have revealed that exposition of host cells to bacteria
(e.g. Bartonella henselae) results in HIF-1a activation and VEGF
secretion in vivo and in vitro [29]. Similar findings were reported
when macrophages were infected with group B streptococci
[17,18]. Therefore, it is obvious that HIF-1 plays a central role in
infections with human bacterial pathogens. This could have
important medical implications in terms of the treatment of sepsis,
as it has been shown that serum VEGF levels (known to be
regulated via HIF-1) are dramatically increased in patients
suffering from septicemia [30] or meningitis [31].
In addition, previous studies have found activation of HIF-1a
during viral infections [32]. For example, previous studies have
suggested a functional role of the hepatitis C virus in HIF
stabilization [33]. Other studies found HIF-1a stabilization during
hepatitis B infections [34] or during infections with the Eppstein-
Barr virus [35]. Respiratory syncytial virus (RSV) is the major
cause of serious lower respiratory disease in infancy and early
childhood [36]. Bronchiolitis, the more severe clinical manifesta-
tion of RSV infection, is characterized by necrosis and sloughing
of the respiratory epithelium and plugging of the small bronchioles
with fibrin and mucus. As such, RSV is characterized by a
particularly prominent inflammation of the pulmonary mucosa-
both in natural and experimental infections [36]. In fact, RSV is
among the most potent biological stimuli that induce the
expression of inflammatory genes, including those encoding
chemokines, and studies on mechanism(s) that control virus-
mediated airway inflammation are currently areas of intense
investigation [37–41]. In fact, a previous studies suggested that
RSV-elicited release of nitric oxide could be associated with HIF-
1a stabilization during RSV infection [42]. Therefore, we
combined in vitro and in vivo approaches to study HIF-1a
activation and gene-transcription during RSV infection.
Methods
Culture of epithelial cells
A549 cells (American Type Culture Collection, Wesel, Ger-
many) were cultured as described previously [38]. In short, A549
were grown in F-12 HAM medium (Invitrogen, Karlsruhe,
Germany) supplemented with 10% fetal bovine serum (Invitrogen,
Karlsruhe, Germany) and 1% Antibiotic-Antimycotic-Solution
(Sigma-Aldrich, Steinheim, Germany). L-Glutamin was adjusted
to a total quantity of 2 mM. The cells were maintained under
standard-conditions of 37uC in 20% O2 and 5% CO2.
Infection with RSV
Human RSV was purified by polyethylene glycol precipitation,
followed by centrifugation on 35 to 65% discontinuous sucrose
gradients as described previously [43,44]. The virus was stored in
aliquots at 280uC until use. Virus titers were determined by a
methylcellulose plaque assay [45]. For experiments with inacti-
vated RSV, the virus was exposed to an UV light source for
20 minutes as described previously [43]. A549 cells were infected
when they reached 70–80% confluence, using different multiplic-
ities of infection (MOI). The virus was added immediately after
removal of the culture medium in a small amount of serum-free
medium for 1 h. Additional media was added and the infection
was continued for indicated time periods [38].
Protein Extraction
Supernatants were discarded and 200 ml Lysis-Buffer (1 mM
Tris-HCl, 250 mM NaCl, 1 mM EDTA, Triton X 100 1%, NP40
16Igepal Electrophoresis Reagent, Aprotinin 1 mg/ml, Leupeptin
1 mg/ml, Pepstatin 1 mg/ml, PMSF 1 mM and OV 1 mM) was
added. After scraping and collecting into tubes, the cell-lysate was
incubated at 4uC for 20 minutes on a rotator. Cell debris was
removed by centrifugation at 13000 g for 15 minutes and
discharged. Protein concentrations were determined using the
BCA
TM Protein Assay Kit (Pierce, Bonn, Germany) according to
the manufacturer’s instructions.
Nuclear Protein Extraction
Nuclear Proteins were isolated from A549 cells using a
modification of methods previously described [46]. In short, cells
were lysed in 500 ml cold buffer A (10 mM Hepes-KOH, pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM Dithiothreitol (DTT),
0.2 mM phenylmethylsulfonyl fluoride (PMSF)), scraped and
collected into tubes and incubated for 15 min on ice. After adding
7,5 ml solution containing 10% NP40, vortexing for 3 seconds
and incubation for three minutes on ice, the tubes were
centrifuged for 2 minutes at 6000 g at 4uC. The cytoplasmic
proteins in the supernatant were collected and flash-frozen. Next,
the pellet was resuspended in 100 ml of cold buffer B (20 mM
Hepes-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF). After
centrifugation (12000 g at 4uC for 30 minutes), the supernatant
was discarded and the pellet was resuspended in 50 ml of buffer C
(25% glycerol, 20 mM Hepes-KOH, pH 7.9, 420 mM NaCl,
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF,
2 mM benzamidine, 5 mg/ml leupeptin) and incubated for
45 minutes at 4uC. Cellular debris was removed by 5 minutes of
centrifugation (6000 g at 4uC) and the supernatant was flash-
frozen at 280uC. Protein concentrations were determined using
the BCA
TM protein assay kit (Pierce, Bonn, Germany) as
instructed by the manufacturer.
Western blotting
Proteins were diluted in radio-immuno precipitation assay
(RIPA) buffer to equivalent protein concentrations. After adding
46 Laemmli sample buffer they were immediately heated for
10 minutes at 70uC, separated on a 12% polyacrylamide gel and
transferred to a nitrocellulose membrane (Polyvinylidene Difluor-
ide, Bio-Rad Laboratories, Inc., Mu ¨nchen, Germany). Rainbow
(Amersham, Buckinghamshire, UK) and MagicMark (Invitrogen,
Karlsruhe, Germany) were used for size analysis and blotting
control. The membranes were blocked overnight at 4uC in TBS
containing 0,05% Tween and supplemented with 3% BSA and
3% skimmed milk. The membranes were then incubated in 1:500
COX2 goat polyclonal IgG (Santa Cruz, Heidelberg, Germany) or
1:500 anti RSV mouse IgG (Acris, Hiddenhausen, Germany) or
1:500 FN goat polyclonal IgG (Santa Cruz, Heidelberg, Germany)
or 1:1000 beta-Actin antibody (Cell Signaling, Danvers, MA) in
HIF during RSV Infection
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with horse-radish-peroxidase-labelled secondary antibodies (goat
anti-rabbit or donkey anti-goat or goat anti-mouse 1:1000; Santa
Cruz, Heidelberg, Germany) for 45 minutes at room temperature.
The wash was repeated and proteins were detected by enhanced
chemiluminescence, using the Chemiluminescent Substrate Kit
(Pierce, Bonn, Germany). Western immunoblotting for HIF1-
alpha was performed using 1:500 Anti-HIF-1a rabbit polyclonal
IgG (upstate, Lake Placid, NY) following the manufacturers
protocol without the use of Tween.
Enzyme-linked immunosorbent assay (ELISA) for
determination of chemokines
Total protein samples of infected or non-infected A549 cells were
tested for VEGF by use of a commercial ELISA kit (R&D Systems,
Minneapolis,MN, USA) as instructed bythe manufacturer. In short,
samples were added to a 96 well microtiter plate, which was coated
with murine monoclonal antibody to VEGF. The unbound protein
was removed by washing and an enzyme linked polyclonal antibody
specific to VEGF was added. After additional washing, substrate
solution was added and incubated for 20 min. The color-reaction
was stopped with stop solution and the amount of VEGF was
determined by optical density of the samples by comparing the
standards at 450 nm using an ELISA reader.
Immunohistochemistry
A549-cells were cultured on glass slides (NalgeNuc Internation-
al, Naperville, IL) and infected with RSV at a MOI of 3. After
24 hours, they were fixed and permeabilized for immunofluores-
cent staining using Cytofix/Cytoperm (PharMingen, BD-Biosci-
ence, Heidelberg, Germany). After two washes with Perm/Wash-
solution (PharMingen, BD-Bioscience, Heidelberg, Germany) the
slides were blocked for 30 minutes with 5% skimmed milk in
Perm/Wash-solution. Purified mouse anti-HIF1a Mab (BD
Transduction Laboratories, BD-Bioscience, Heidelberg, Ger-
many) and anti-RSV mouse IgG (Acris, Hiddenhausen, Germany)
were diluted 1:100 in Perm/Wash-solution and the slides were
incubated for 30 minutes. Normal mouse and normal rabbit
control IgG in a dilution of 1:200 were used. After two washes with
Perm/Wash-solution, the slides were incubated for 30 minutes
with the secondary antibodies (Alexa Fluor 488 goat anti-rabbit
IgG and Alexa Fluor 594 goat anti-mouse IgG, Invitrogen,
Karlsruhe, Germany) in Perm/Wash. The slides were embedded
with a reagent containing DAPI (Invitrogen, Karlsruhe, Germany)
for staining of the nuclei. Fluorescence was visualized with a
confocal laser scanning microscope (Leica, Bensheim, Germany).
Reverse Transcription Polymerase Chain Reaction
Analysis
Realtime RT-PCR (iCycler; Bio-Rad Laboratories Inc., Her-
cules, California, USA), was used to verify COX2, FN-1, VEGF
and CD73 transcript levels of RSV-infected A549 cells. After
infection with RSV with an infection dose of MOI3 for 24 h, total
RNA was isolated using the RNA II Kit (Macherey & Nagel,
Du ¨ren, Germany) and real-time RT-PCR was performed as
described previously [47–52]. The PCR reaction contained 10 pM
each of the sense primer 59-AAA CCT CAG CTC AGG ACT
GC-39 and the antisense primer 59-GGC ACT AGC CTC TTT
GCA TC-39 for COX2, sense primer 59-AAG GAA GGG GAA
GAA CAG GA-39 and the antisense primer 59-GGC AGA GCT
GAT GGA ATC TC-39 for CD73, sense primer 59-TTG CCT
TGC TGC TCT ACC TC-39 and the antisense primer 59-AGC
TGC GCT GAT AGA CAT CC-39 for VEGF, sense primer 59-
AGG CTC AGC AAA TGG TTC AG-39 and the antisense
primer 59-TCG GCT TCC TCC ATA ACA A-39 for FN1. The
primer set for COX2, FN1 and VEGF was amplified using
increasing numbers of cycles of 95uC for 15 sec, 58uC for 30 sec,
72uC for 10 sec, and a final extension of 72uC for 1 minute. The
primer set for CD73 was amplified using increasing numbers of
cycles of 95uC for 15 sec, 60uC for 30 sec, 72uC for 10sec, and a
final extension of 72uC for 1 minute. Human beta-actin (sense
primer, 59-GGT GGC TTT TAG GAT GGC AAG-39; and
antisense primer, 59-ACT GGA ACG GTG AAG GTG ACA G-
39) was used as control.
Stable repression of HIF-1a by siRNA
Repression of HIF-1a by siRNA was achieved based on a
modification of methods previously described [26,53–56]. In short, a
hairpin primer with the sequence 59-ACCTCGCTGACCAGT-
TATGATTGT-GATCAAGAGTCACAATCATAACTGGTCA-
GCTT-39 and 59-CAAAAAGCTGACCAG-TTATGATTGTGA-
CTCTTGATCACAATCATAACTGGTCAGCG-39 correspond-
ingtoposition2666-2685oftheHIF1agenewasselected.A549-cells
were transfected using electroporation, followed by selection with
G418 (1 mg/ml). The control cell line was transfected with a non-
specific control psiRNA-hH1 neoscr plasmid.
Blood Gas Analysis
Blood gas analysis was performed to assess oxygen partial
pressure in supernatants of uninfected or infected A549 cells. The
cells were cultured and infected at a MOI of 1 or 5. One hour after
infection the cell-culture flasks were filled up with serum free
media and were sealed gas-tight. Analysis of the supernatants was
performed immediately after removal via the I-STAT Analyzer
(Abbott, Wiesbaden, Germany) at different time points as
described previously [19,52].
Infection of mice with RSV and extraction of lung nuclear
proteins
Female, 6- to 8-week-old BALB/c mice were purchased from
Harlan (Houston, Texas, USA) and were housed in pathogen-free
conditions in the animal research facility of the University Texas
Medical Branch (UTMB), Galveston, Texas, in accordance with
the National Institutes of Health and UTMB institutional
guidelines for animal care. The Institutional Animal Care and
Use Committee approved this protocol. Cages, bedding, food, and
water were sterilized before use. Under light anesthesia, female, 6-
8 weeks old BALB/c mice were infected intranasally with RSV at
1610
7 plaque-forming units (PFUs), diluted in sterile PBS for a
total inoculation volume of 50 ml. As mock treatment, control mice
were inoculated in the same way with an equivalent volume of
sucrose diluted in PBS. At the indicated time points after infection
(12, 24 and 48 h) mice were anesthetized with an intraperitoneal
injection of ketamine and xylazine before the thoracic cavity was
opened [39]. Lungs were then removed, quick frozen in liquid
nitrogen and stored at 280uC until nuclear protein was isolated.
Nuclear proteins were isolated from the lung tissue using a
modified method described by Bohrer and colleagues [46]. Lung
tissue was homogenized in 5 ml ice-cold Buffer A (10 mM 2-
hydroxyethyl-piperazine N9-2-ethanesulfonic acid [Hepes]–KOH,
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol
[DTT], 0.2 mM phemylmethyl sulfonyl fluoride [PMSF], 0.6%
nonident P40 [NP-40]) and centrifuged at 3506g, 4uC for
30 seconds. The supernatant was kept on ice for 5 minutes and
centrifuged for 5 minutes at 6,0006ga t4 uC, and the pellet was
resuspended in 200 ml Buffer B (10 mM Hepes–KOH, pH 7.9,
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0.2 mM PMSF). After centrifugation (13,0006g, 4uC, 30 min-
utes), the pellet was resuspended in 100 ml Buffer C (20 mM
Hepes–KOH, pH 7.9, 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM
ethylenediamine-tetraacetic acid, 0.5 mM DTT, 0.2 mM PMSF,
2 mM benzamidine, 5 mg/ml leupeptin, 25% glycerol), incubated
on ice for 20 minutes, and centrifuged (6,0006g, 4uC, 2 minutes).
The supernatant was quick frozen in aliquots at 280uC. HIF-1a
stabilization was determined by Western blot analysis as described
previously [56].
Statistical Analysis
Data collection and statistical analysis was performed using
Microsoft Excel (Microsoft Office Professional Edition 2003) and
Graph Pad Prism (GraphPad Software Inc., Prism 4 for Windows
Version 4.03). All presented values were calculated as the mean
from at least three separate experiments. The results in the control
and the viral infection group were analyzed and compared by
utilizing the Unpaired Student t Test and the Mann-Whitney
Nonparametric Test. For all statistical analyses a P value,0.05
was considered significant.
Results
Immunolocalization of HIF-1a during RSV infection in
vitro
Recent evidence revealed that numerous parallels exist
between inflammation and hypoxia, including changes in barrier
function or inflammatory cell recruitment [5,6,55,57–60]. In
addition, recent studies have revealed that during infections with
human pathogens, HIF-1a is activated [19,29]. Previous studies
demonstrated that RSV infections are characterized by a
particularly prominent inflammation of the pulmonary mucosa-
both in natural and experimental infections-and RSV is among
the most potent biological stimuli that induce the expression of
pro-inflammatory genes [36]. Therefore, we hypothesized that
HIF-1a is stabilized during infections with RSV and may
contribute to RSV-associated changes in gene expression. For
our studies, we used A549 cells, a cell line derived from an
alveolar cell carcinoma of the lung. As first step, we performed
immunohistochemical staining with antibodies for RSV (green)
or HIF-1a (red) using confocal laser scanning microscopy
(Figure 1A). As counterstaining for the nuclei we used dapi
staining (blue). As shown in Figure 1A, RSV infected cells also
stained positive for HIF-1a, with localization of HIF-1a both in
the cytosole and the nuclei. This is consistent with other studies
demonstrating that HIF-1a is present in the cytosole and in the
nucleus [61]. In contrast, uninfected A549 cells only had a very
week signal for HIF-1a (Figure 1B). Isotype controls and staining
of infected A549 cells with secondary antibody alone were
negative (data not shown). Taken together, these data reveal that
during RSV infection, HIF-1a accumulates in the cytosole and
the nucleus of infected pulmonary epithelia, suggesting HIF-1a
activation during RSV infection in vitro.
HIF-1a protein is stabilized during RSV infection
After having shown by confocal laser scanning microscopy that
HIF-1a is stabilized during RSV infection, we next used Western
blot analysis to confirm these results with a more quantitative
approach. Here, we first confirmed successful infection of A549
cells using different infection doses (MOI1-5). As shown in
Figure 2A, we found a close correlation of virus load with RSV
G-protein after 24 h of infection (Figure 2A). In contrast, RSV
pre-exposed to UV light source as previously described for RSV
inactivation [43] showed no signal for intracellular RSV G-
protein. Uninfected cells were used as negative control. As next
step, we measured HIF-1a during RSV infection by Western blot
analysis. These studies revealed an 8.265.2-fold increase in HIF-
1a protein compared to non-infected A549 cells (Figure 2B and C,
relative to beta-actin, MOI of 3). Interestingly, this HIF-response
was completely attenuated when using UV-treated RSV virus
(0.960.42-fold HIF-1a protein relative to beta-actin, Figure 2 B
and C). In additional control studies, we exposed A549 cells to
ambient hypoxia (2% oxygen over 24 h), which was associated
with a robust increase in HIF-1a protein (6.564.3-fold increase in
HIF-1a). Taken together, these studies reveal robust stabilization
of HIF-1a during infection with life RSV in vitro.
Figure 1. HIF-1a during RSV infected of pulmonary epithelia.
(A) ,1,5610
5 A549-cells were seeded on glass slides and infected with
RSV (multiplicity of infection, MOI 3). After 24 h they were fixed,
permeabilized and incubated with anti-HIF1a and anti-RSV IgG as
primary antibodies. Alexa Fluor 488 and Alexa Fluor 594 were used for
staining. In addition, slides were counter-stained with Dapi. The cells
were visualized with confocal laser scanning microscopy. Uninfected
cells were used as controls (B).
doi:10.1371/journal.pone.0003352.g001
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After having demonstrated HIF-1a protein stabilization during
infection with RSV, we next pursued functional consequences of
HIF-1a in transcriptional gene induction during RSV infection.
For this purpose, we performed expressional studies of known
HIF-1-dependent genes during RSV infection. Thus, we measured
transcript levels of CD73 [62], VEGF [63], Fibronectin1 (FN1)
[64] and COX2 [65] after 24 h of RSV infection of A549
pulmonary epithelial cells using different RSV infection doses
(MOI1-5). As shown in Figure 3, analysis of transcript levels by
real-time RT-PCR revealed induction of all tested HIF-1 target
genes. Extensions of these findings at the protein level by Western
blot confirmed significant induction of COX2 or FN1 protein
levels (Figure 4A and B). Similarly, measurements of VEGF in the
supernatants from RSV infected pulmonary epithelial cells
revealed significantly elevated levels of VEGF (data not shown).
Taken together, these studies demonstrate induction of HIF-1a -
depedendent genes during RSV infection in vitro.
HIF-dependent gene expression during RSV infection in
pulmonary epithelial cells following siRNA repression of
HIF-1a
To demonstrate a functional role of HIF-1a in the observed
induction of HIF-dependent genes induction during RSV
infection, we next pursued HIF-1a-loss-of-function studies. For
this purpose, we generated a pulmonary epithelial cell line (A549
cells) with stable repression of HIF-1a. This was achieved via
hairpin siRNA technique as we have done previously in other cell
lines [26,53–56]. To demonstrate effective repression of HIF-1a in
these cell lines, we utilized a model of ambient hypoxia. For this
purpose, we exposed these cells to hypoxia over 24 or 48 h (2%
oxygen), while growth-synchronized control cells were maintained
at room air (21% oxygen). These studies revealed significant
accumulation of HIF-1a protein in control transfected cells in
conjunction with attenuated HIF-1 a stabilization in HIF-1 a-
siRNA-transfected A549 cells (Figure 5A and B). We utilized this
model to directly test the functional role of HIF-1a in
transcriptional modulation during RSV infection. Here, we
measured transcript levels of control transfected or HIF-1a-
targeted pulmonary epithelia. These studies revealed significant
induction of HIF-1-target genes (VEGF, CD73 or FN1) in control
cells, while these responses were abolished in HIF-1a-targeted
pulmonary epithelia. Taken together, these studies suggest a
functional role of HIF-1 a in transcriptional induction of HIF-1a -
targeted genes during infection with RSV.
Influence of UV-inactivation of RSV on HIF-dependent
gene induction
In view of the above results, we hypothesized that only intact
RSV is capable of HIF-1 a stabilization and induction of HIF-1a
target genes. Therefore, we next investigated the effects of UV-
inactivated virus on the HIF-1 a target genes. For this purpose, we
measured VEGF, CD73, FN1 and COX2 transcript levels in
A549 cells that were infected with intact or with UV-inactivated
RSV (Figure 6 A-D). Consistent with our studies above, we found
significant induction of HIF-1a target genes in RSV infected A549
cells. In contrast, induction of HIF-1a target genes was completely
abolished after similar infection doses with UV-inactivated RSV.
Taken together, these studies suggest that only functional RSV
virus, capable of intracellular replication–is necessary to cause
HIF-1a-dependent gene induction.
Figure 2. HIF-1a protein measurements during RSV infection in
vitro. (A, B) Cultured pulmonary epithelia (A549) were grown to 80%
confluency, infected with intact (multiplicity of infection, MOI 1, 3 or 5)
or UV-inactivated RSV (MOI 3). In other studies A549 cells were exposed
over 24 h to ambient hypoxia (2% oxygen). Cells were lysed and nuclear
proteins were isolated, and Western immunoblotting for RSV G-protein
(A) or HIF1a was performed. Uninfected cells were used as control (Co).
The same blots were probed for b-actin expression as a control for
protein loading. A representative blot of 3 is shown, in addition to
densitometric analysis of HIF-1a protein levels relative to b-actin
(C;*P,.01, different from control, n = 3).
doi:10.1371/journal.pone.0003352.g002
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Previous studies of infection and inflammation have revealed
significant changes in metabolic supply and demand. For example,
studies of murine colitis revealed convincing evidence that the
mucosal surface is prone to inflammation-associated hypoxia
[58,66]. Our above studies showed that intracellular uptake and
binding of RSV appears to be necessary for HIF-1a dependent
gene induction. Therefore, we hypothesized that changes in
metabolic supply and demand ratios during RSV infection may
accompany RSF-infection and RSV-associated tissue hypoxia
could lead to HIF-1a activation. To address this hypothesis in an
experimental setting, we measured oxygen partial pressures (pO2)
values in the supernatants from RSV infected pulmonary epithelia
or controls that were maintained in an oxygen impermeable
culture system. As shown in Figure 7A, no differences in PO2
values were observed between experimental groups. In fact,
neither supernatant from control nor RSV-infected pulmonary
epithelia showed significant degrees of hypoxia. Consistent with
these findings, and as shown in Figure 7B, Western blot analysis
confirmed that HIF-1a was not stabilized in control cells
maintained under the above cell culture conditions at 24 h.
Similarly, HIF-1a stabilization was not observed at earlier time
points (date not shown). In contrast, we observed significant HIF-
1a stabilization in RSV-infected pulmonary epithelia. Taken
together, these studies suggest oxygen independent stabilization of
HIF-1a during RSV infection.
HIF-1 a is stabilized during murine RSV infection in vivo
As proof of principle for these concepts in vivo, we compared the
influence of RSV infection on pulmonary HIF-1a stabilization using
a previously described model [38–41]. This mouse model shows
close similarity to the pathogenesis of RSV-induced lower airway
disease in humans. In fact, recently established that the experimental
infection of BALB/c mice with highly purified preparations of RSV
A, at a dose of 10
7 PFU, induces a severe inflammatory response in
lung tissue as early as 24 h after intranasal inoculation [39]. Lung
inflammation was characterized by an excess of monocytes/
macrophages, lymphocytes, and to a lesser extent, neutrophils
surrounding bronchioles and vessels, with evidence of the involve-
ment of alveolar spaces [39]. In the present studies, female BALB/c
mice were inoculated intranasally with purified RSV. In control
experiments, BALB/cmicematched inage,gender and weightwere
inoculated in the same way with an equivalent volume of vehicle. At
the indicated time points after infection, mice were anesthetized,
lungswereshockfrozen andHIF-1a was determined by Western blot
analysis. As shown in Figure 8A and B, HIF-1 a was stabilized with
RSV infection at allmeasurement timepoints. Taken together, these
data confirm our in vitro findings and suggest that during murine
RSV pneumonia HIF-1a is stabilized.
Discussion
Many studies during the last decade have demonstrated a
central role of HIF-1 in mammalian oxygen homeostasis [3].
However, more recently many studies have also demonstrated a
role of HIF-1a in the transcriptional coordination during
inflammation and infection [6,32,54,67]. In fact, previous studies
have revealed that HIF-1a can be stabilized during infections with
human pathogens via oxygen-dependent [67] or oxygen indepen-
dent [54] pathways. In the present studies we pursued HIF-1a
stabilization and gene-transcription during infection with RSV–
one of the most potent biological stimuli to induce an
inflammatory milieu [38–41]. In initial studies of cultured
pulmonary epithelia infected with RSV revealed stabilization of
HIF-1a protein. Moreover, transcription of known HIF-1a target
genes was induced following RSV infection, while siRNA-
dependent repression of HIF-1a abolished these responses.
However, infection with RSV was not associated with increased
oxygen consumption or cellular hypoxia, suggesting that HIF-1a
stabilization and HIF-dependent gene induction during RSV
Figure 3. Transcript levels of HIF-1-dependent genes following
RSV infection. Total RNA was isolated from RSV-infected (multiplicity
of infection, MOI 1, 3 and 5) or non-infected A549 cells (control) and (A)
CD73, (B) VEGG, (C) FN1, (D) COX2 mRNA levels were determined by
real-time RT-PCR. Data were calculated relative to internal housekeep-
ing gene (b-actin) and are expressed as fold increase over uninfected
control-cells 6SEM at each infection dose (*P,0.05, different from
uninfected control-cells).
doi:10.1371/journal.pone.0003352.g003
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of murine RSV pneumonia revealed significant HIF-1a stabiliza-
tion throughout the course of the disease and suggest that RSV-
associated HIF-1a activation also occurs in vivo.
Previous studies of HIF-1a during inflammation and infection
have found oxygen-independent activation of HIF-1a during
infections with human pathogens. For example, a recent study on
molecular mechanisms of how bacteria activate HIF-1a found a
role of bacterial siderophores in HIF-1a activation during infection
with Enterobacteriaceae [54]. Here, the authors studied HIF-1a
activation and HIF-1a -dependent gene induction in Peyer’s
patches that were analyzed after orogastric infection with Yersinia
enterocolitica and orogastric Y enterocolitica infection in mice with
a conditional deletion of HIF-1a [66] in the intestine. These studies
demonstrated that infection of mice with Y enterocolitica led to
functional activation of HIF-1a in Peyer’s patches. Moreover, mice
with conditional deletion of HIF-1a in the intestinal epithelium
showed a significantly higher susceptibility to orogastric Y
Figure 4. Protein levels of HIF-1-dependent genes following RSV infection. Total protein was isolated from RSV-infected (multiplicity of
infection, MOI 1, 3 and 5) or non-infected A549 cells. Protein levels were determined by Western blot. The same blots were probed for b-actin
expression as a control for protein loading. In addition, densitometric analysis of protein levels relative to b-actin were performed. Data are expressed
as fold increase over uninfected control-cells 6SEM at each infection dose. (A) COX2; (B) FN1 (*P,0.01, different from control, n = 3).
doi:10.1371/journal.pone.0003352.g004
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defense mechanism in this model. Additional studies with Y
enterocolitica, S enterica subsp enterica, or E aerogenes, and,
moreover, application of their siderophores (yersiniabactin,
salmochelin, aerobactin) caused a robust, dose-dependent HIF-
1a response in human epithelia and endothelia, independent of
cellular hypoxia. Taken together, such studies demonstrate a role
for bacterial siderophores in hypoxia-independent activation of
HIF-1a during infection with human pathogenic bacteria
[54].Similarly, previous studies on viral infections with RSV have
demonstrated induction of HIF-1a in primary human bronchial
epithelial cells via a nitric-oxide-dependent pathway [42]. Other
studies have identified a crosstalk between viral genes and the HIF-
1a pathway during infections with the human herpesvirus 8 (HHV-
8) [32,68]. Kaposi’s sarcoma-associated herpesvirus (KSHV or
HHV-8) is the etiological agent of Kaposi’s sarcoma, a highly
vascularized, endothelial-derived tumor. A direct role for KSHV-
mediated induction of angiogenesis has been proposed based upon
the nature of the neoplasia and various KSHV gene overexpression
and infection model systems. These studies revealed that KSHV
infection of endothelial cells induces mRNA of HIF-1a and HIF-
2a. While HIF is classically activated posttranscriptionally, these
Figure 5. Transcript levels of HIF-dependent genes following
HIF-1a siRNA repression during RSV infection. (A) HIF-1a protein
levels in A549 cells following hairpin siRNA repression of HIF-1a (HIF-/-;
A549 cells transfected with control siRNA:SCR). Cells were grown to 80%
confluency and exposed to normoxia or hypoxia (2% oxygen) over
indicated time period. Nuclear proteins were isolated and Western Blot
analysis was performed for HIF-1a. The same blots were probed for b-
actin expression as a control for protein loading. A representative blot
of 3 is shown, in addition to densitometric analysis of HIF-1a protein
levels relative to b-actin (B;*P,0.01, different from control, n = 3).(C, D,
E) Total RNA was isolated from RSV-infected (multiplicity of infection,
MOI 3) or non-infected A549 following HIF-1a repression (A549 HIF-/-)
or transfection with control siRNA (A549 scr). (C) VEGF, (D) CD73, (E) FN1
transcript levels were determined by RT-PCR. Data were calculated
relative to internal housekeeping gene (b-actin) and are expressed as
fold increase over uninfected control-cells 6SEM (*P,0.05).
doi:10.1371/journal.pone.0003352.g005
Figure 6. Transcript levels of HIF-dependent genes following
infection with inactivated RSV. Total RNA was isolated from
uninfected, RSV-infected or UV-inactivated RSV infected A549 cells. (A)
VEGF, (B) CD73, (C) FN1, (D) COX2 transcript levels were determined by
real-time RT-PCR. Data were calculated relative to internal housekeep-
ing gene (b-actin) and are expressed as fold increase over uninfected
control-cells 6SEM at each infection dose (*P,0.05, different from
uninfected control-cells).
doi:10.1371/journal.pone.0003352.g006
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the transcript level by KSHV infection. Here, the transcriptional
activation of HIF leads to a functional increase in HIF activity
under normoxic conditions, as shown utilizing luciferase reporter
assays and HIF-dependent gene expression.
From the present studies it remains unclear whether HIF-1a
activation during RSV infection represents a host-defense
mechanism or is an essential part of the disease pathogenesis
enabling virus uptake or replication. While some studies have
identified a host-protective role of HIF-1a during inflammation
[25–27,53,54,69] or infections [54], other studies have found a
contribution of HIF-1a activation in growth and survival of
human pathogens. For example, Toxoplasma gondii is an obligate
intracellular protozoan pathogen. Recent studies revealed that
genes mediating cellular responses to hypoxia were upregulated in
Toxoplasma -infected cells but not in cells infected with another
intracellular pathogen, Trypanosoma cruzi [70,71]. The inducible
expression of these genes is controlled by the HIF-1a. Additional
studies revealed that Toxoplasma infection rapidly increased the
abundance of the HIF1a and activated HIF-1a reporter gene
expression and survival was severely reduced in cells targeted for
HIF-1a [72]. These studies also suggested that while HIF-1a was
not required for parasite invasion, HIF-1a was required for
parasite cell division and organelle maintenance, indicating that
Toxoplasma activates HIF-1a and requires HIF-1a for growth
and survival at physiologically relevant oxygen levels [70–72].
Taken together, the present studies reveal oxygen-independent
stabilization of HIF-1a during RSV infection in vitro and in vivo.
Future challenges will include the determination whether such
responses elicited during RSV infections are host-protective or host-
detrimental. In addition, it will be critical to gather a more thorough
understanding of the mechanisms of HIF-1a induction during RSV
infection (e.g. the role of RSV elicited TLR signaling in HIF
stabilization) or the contribution of RSV-associated nitric oxide
release [42]. Ongoing studies are currently testing HIF-activation or
HIF-inhibition in different settings of medical therapy and novel
therapeutics will soon become available in patient care to inhibit or
Figure 7. (a) Measurements of oxygen partial pressures (pO2) in the
supernatants of RSV infected pulmonary epithelia. (A) A549 cells were
cultured and infected at a multiplicity of infection (MOI) of 1 or 5 in gas-
tight sealed flasks. Oxygen partial pressure was measured in the
supernatants at indicated time points following infection. (B) A samples
was assessed for HIF-1a protein levels by Western blot 24 h after RSV
infection or control conditions. Blots were probed for b-actin expression
as a control for protein loading
doi:10.1371/journal.pone.0003352.g007
Figure 8. HIF-1a protein during murine RSV pneumonia in vivo.
Female, 6- to 8-week-old BALB/c mice were inoculated intranasally with
purified RSV at 1610
7 plaque-forming units (PFUs), diluted in sterile 0.9
% sodium chloride for a total inoculation volume of 50 ml. As mock
treatment, control mice were inoculated in the same way with an
equivalent volume of sucrose diluted in 0.9 % sodium chloride. Lungs
were removed at indicated time-points, and HIF-1a protein levels were
determined by Western blot analysis (A) or quantified by densitometry,
relative to beta-actin (B; *p,0.01).
doi:10.1371/journal.pone.0003352.g008
HIF during RSV Infection
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novel approach during RSV infections.
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